 | • レポートコード：GIR-203B16381 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 外陰部・膣用萎縮治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の外陰部・膣用萎縮治療の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の外陰部・膣用萎縮治療の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 外陰部・膣用萎縮治療市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・外陰部萎縮治療、膣萎縮治療 用途別セグメントは次のように区分されます。 ・病院、外来手術センター、専門クリニック、その他 世界の外陰部・膣用萎縮治療市場の主要な市場プレーヤーは以下のとおりです。 ・Almirall、VenusConcept、Alma Lasers、ThermiGen LLC、Lutronic、BTL Group of Companies、Viveve、Fotona、Hologic 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、外陰部・膣用萎縮治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な外陰部・膣用萎縮治療メーカーの企業概要、2019年～2021年までの外陰部・膣用萎縮治療の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な外陰部・膣用萎縮治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別外陰部・膣用萎縮治療の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの外陰部・膣用萎縮治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での外陰部・膣用萎縮治療市場予測を収録しています。 ・第12、13、14章では、外陰部・膣用萎縮治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Almirall、VenusConcept、Alma Lasers、ThermiGen LLC、Lutronic、BTL Group of Companies、Viveve、Fotona、Hologic ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：外陰部萎縮治療、膣萎縮治療 ・用途別分析2016年-2026年：病院、外来手術センター、専門クリニック、その他 ・外陰部・膣用萎縮治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・外陰部・膣用萎縮治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・外陰部・膣用萎縮治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・外陰部・膣用萎縮治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・外陰部・膣用萎縮治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vulvar and Vaginal Atrophy Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vulvar and Vaginal Atrophy Therapy size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Vulvar and Vaginal Atrophy Therapy market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Vulvar and Vaginal Atrophy Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vulvar Atrophy Therapy
Vaginal Atrophy Therapy
Market segment by Application can be divided into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
The key market players for global Vulvar and Vaginal Atrophy Therapy market are listed below:
Almirall
VenusConcept
Alma Lasers
ThermiGen LLC
Lutronic
BTL Group of Companies
Viveve
Fotona
Hologic
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vulvar and Vaginal Atrophy Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vulvar and Vaginal Atrophy Therapy, with price, sales, revenue and global market share of Vulvar and Vaginal Atrophy Therapy from 2019 to 2021.
Chapter 3, the Vulvar and Vaginal Atrophy Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vulvar and Vaginal Atrophy Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vulvar and Vaginal Atrophy Therapy market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vulvar and Vaginal Atrophy Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Vulvar and Vaginal Atrophy Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vulvar and Vaginal Atrophy Therapy Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Vulvar Atrophy Therapy
1.2.3 Vaginal Atrophy Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Vulvar and Vaginal Atrophy Therapy Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Vulvar and Vaginal Atrophy Therapy Market Size & Forecast
1.4.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Value (2016-2026))
1.4.2 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume (2016-2026)
1.4.3 Global Vulvar and Vaginal Atrophy Therapy Price by Type (2016-2026) & (US$/Unit)
1.5 Global Vulvar and Vaginal Atrophy Therapy Production Capacity Analysis
1.5.1 Global Vulvar and Vaginal Atrophy Therapy Total Production Capacity (2016-2026)
1.5.2 Global Vulvar and Vaginal Atrophy Therapy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vulvar and Vaginal Atrophy Therapy Market Drivers
1.6.2 Vulvar and Vaginal Atrophy Therapy Market Restraints
1.6.3 Vulvar and Vaginal Atrophy Therapy Trends Analysis
2 Manufacturers Profiles
2.1 Almirall
2.1.1 Almirall Details
2.1.2 Almirall Major Business
2.1.3 Almirall Vulvar and Vaginal Atrophy Therapy Product and Services
2.1.4 Almirall Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 VenusConcept
2.2.1 VenusConcept Details
2.2.2 VenusConcept Major Business
2.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Product and Services
2.2.4 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Alma Lasers
2.3.1 Alma Lasers Details
2.3.2 Alma Lasers Major Business
2.3.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Product and Services
2.3.4 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 ThermiGen LLC
2.4.1 ThermiGen LLC Details
2.4.2 ThermiGen LLC Major Business
2.4.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product and Services
2.4.4 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Lutronic
2.5.1 Lutronic Details
2.5.2 Lutronic Major Business
2.5.3 Lutronic Vulvar and Vaginal Atrophy Therapy Product and Services
2.5.4 Lutronic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 BTL Group of Companies
2.6.1 BTL Group of Companies Details
2.6.2 BTL Group of Companies Major Business
2.6.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product and Services
2.6.4 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Viveve
2.7.1 Viveve Details
2.7.2 Viveve Major Business
2.7.3 Viveve Vulvar and Vaginal Atrophy Therapy Product and Services
2.7.4 Viveve Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Fotona
2.8.1 Fotona Details
2.8.2 Fotona Major Business
2.8.3 Fotona Vulvar and Vaginal Atrophy Therapy Product and Services
2.8.4 Fotona Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hologic
2.9.1 Hologic Details
2.9.2 Hologic Major Business
2.9.3 Hologic Vulvar and Vaginal Atrophy Therapy Product and Services
2.9.4 Hologic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vulvar and Vaginal Atrophy Therapy Sales by Manufacturer
3.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vulvar and Vaginal Atrophy Therapy
3.4 Market Concentration Rate
3.4.1 Top 3 Vulvar and Vaginal Atrophy Therapy Manufacturer Market Share
3.4.2 Top 6 Vulvar and Vaginal Atrophy Therapy Manufacturer Market Share
3.5 Global Vulvar and Vaginal Atrophy Therapy Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vulvar and Vaginal Atrophy Therapy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vulvar and Vaginal Atrophy Therapy Market Size by Region
4.1.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Region (2016-2026)
4.1.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2016-2026)
4.2 North America Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026)
4.3 Europe Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026)
4.4 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026)
4.5 South America Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026)
4.6 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Type (2016-2026)
5.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Type (2016-2026)
5.3 Global Vulvar and Vaginal Atrophy Therapy Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Application (2016-2026)
6.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Application (2016-2026)
6.3 Global Vulvar and Vaginal Atrophy Therapy Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2026)
7.2 North America Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2026)
7.3 North America Vulvar and Vaginal Atrophy Therapy Market Size by Country
7.3.1 North America Vulvar and Vaginal Atrophy Therapy Sales in Volume by Country (2016-2026)
7.3.2 North America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2026)
8.2 Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2026)
8.3 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country
8.3.1 Europe Vulvar and Vaginal Atrophy Therapy Sales in Volume by Country (2016-2026)
8.3.2 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2026)
9.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2026)
9.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Region
9.3.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2026)
10.2 South America Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2026)
10.3 South America Vulvar and Vaginal Atrophy Therapy Market Size by Country
10.3.1 South America Vulvar and Vaginal Atrophy Therapy Sales in Volume by Country (2016-2026)
10.3.2 South America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2026)
11.2 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2026)
11.3 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country
11.3.1 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vulvar and Vaginal Atrophy Therapy Typical Distributors
12.3 Vulvar and Vaginal Atrophy Therapy Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vulvar and Vaginal Atrophy Therapy Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vulvar and Vaginal Atrophy Therapy Revenue by Application, (USD Million), 2021-2026
Table 3. Almirall Basic Information, Manufacturing Base and Competitors
Table 4. Almirall Major Business
Table 5. Almirall Vulvar and Vaginal Atrophy Therapy Product and Services
Table 6. Almirall Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. VenusConcept Basic Information, Manufacturing Base and Competitors
Table 8. VenusConcept Major Business
Table 9. VenusConcept Vulvar and Vaginal Atrophy Therapy Product and Services
Table 10. VenusConcept Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Alma Lasers Basic Information, Manufacturing Base and Competitors
Table 12. Alma Lasers Major Business
Table 13. Alma Lasers Vulvar and Vaginal Atrophy Therapy Product and Services
Table 14. Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. ThermiGen LLC Basic Information, Manufacturing Base and Competitors
Table 16. ThermiGen LLC Major Business
Table 17. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product and Services
Table 18. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lutronic Basic Information, Manufacturing Base and Competitors
Table 20. Lutronic Major Business
Table 21. Lutronic Vulvar and Vaginal Atrophy Therapy Product and Services
Table 22. Lutronic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BTL Group of Companies Basic Information, Manufacturing Base and Competitors
Table 24. BTL Group of Companies Major Business
Table 25. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product and Services
Table 26. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Viveve Basic Information, Manufacturing Base and Competitors
Table 28. Viveve Major Business
Table 29. Viveve Vulvar and Vaginal Atrophy Therapy Product and Services
Table 30. Viveve Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Fotona Basic Information, Manufacturing Base and Competitors
Table 32. Fotona Major Business
Table 33. Fotona Vulvar and Vaginal Atrophy Therapy Product and Services
Table 34. Fotona Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hologic Basic Information, Manufacturing Base and Competitors
Table 36. Hologic Major Business
Table 37. Hologic Vulvar and Vaginal Atrophy Therapy Product and Services
Table 38. Hologic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Vulvar and Vaginal Atrophy Therapy Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Vulvar and Vaginal Atrophy Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Vulvar and Vaginal Atrophy Therapy Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Vulvar and Vaginal Atrophy Therapy Production Site of Key Manufacturer
Table 44. Vulvar and Vaginal Atrophy Therapy New Entrant and Capacity Expansion Plans
Table 45. Vulvar and Vaginal Atrophy Therapy Mergers & Acquisitions in the Past Five Years
Table 46. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2016-2021e) & (K Units)
Table 47. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2021-2026) & (K Units)
Table 48. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 51. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 52. Global Vulvar and Vaginal Atrophy Therapy Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Vulvar and Vaginal Atrophy Therapy Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2016-2021e) & (US$/Unit)
Table 55. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2021-2026) & (US$/Unit)
Table 56. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 57. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 58. Global Vulvar and Vaginal Atrophy Therapy Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Vulvar and Vaginal Atrophy Therapy Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Vulvar and Vaginal Atrophy Therapy Price by Application (2016-2021e) & (US$/Unit)
Table 61. Global Vulvar and Vaginal Atrophy Therapy Price by Application (2021-2026) & (US$/Unit)
Table 62. North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2016-2021e) & (K Units)
Table 63. North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units)
Table 64. North America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 67. North America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 68. North America Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 69. North America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 70. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units)
Table 72. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 76. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 86. South America Vulvar and Vaginal Atrophy Therapy Sales by Country (2016-2021e) & (K Units)
Table 87. South America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units)
Table 88. South America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 91. South America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 92. South America Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 93. South America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Vulvar and Vaginal Atrophy Therapy Typical Distributors
Table 105. Vulvar and Vaginal Atrophy Therapy Typical Customers
List of Figures
Figure 1. Vulvar and Vaginal Atrophy Therapy Picture
Figure 2. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type in 2020
Figure 3. Vulvar Atrophy Therapy
Figure 4. Vaginal Atrophy Therapy
Figure 5. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centers
Figure 8. Specialty Clinics
Figure 9. Others
Figure 10. Global Vulvar and Vaginal Atrophy Therapy Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Vulvar and Vaginal Atrophy Therapy Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Vulvar and Vaginal Atrophy Therapy Sales (2016-2026) & (K Units)
Figure 13. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Vulvar and Vaginal Atrophy Therapy Production Capacity (2016-2026) & (K Units)
Figure 15. Global Vulvar and Vaginal Atrophy Therapy Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Vulvar and Vaginal Atrophy Therapy Market Drivers
Figure 17. Vulvar and Vaginal Atrophy Therapy Market Restraints
Figure 18. Vulvar and Vaginal Atrophy Therapy Market Trends
Figure 19. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Manufacturer in 2020
Figure 20. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Manufacturer in 2020
Figure 21. Vulvar and Vaginal Atrophy Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Vulvar and Vaginal Atrophy Therapy Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Vulvar and Vaginal Atrophy Therapy Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2016-2026)
Figure 25. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2016-2026)
Figure 26. North America Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026) & (USD Million)
Figure 27. Europe Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026) & (USD Million)
Figure 29. South America Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue (2016-2026) & (USD Million)
Figure 31. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2016-2026)
Figure 32. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2016-2026)
Figure 33. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 35. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2016-2026)
Figure 36. Global Vulvar and Vaginal Atrophy Therapy Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2016-2026)
Figure 38. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 39. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2016-2026)
Figure 40. North America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2016-2026)
Figure 41. United States Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2016-2026)
Figure 45. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 46. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2016-2026)
Figure 47. Europe Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2016-2026)
Figure 48. Germany Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2016-2026)
Figure 57. China Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2016-2026)
Figure 64. South America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 65. South America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2016-2026)
Figure 66. South America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Vulvar and Vaginal Atrophy Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
プラスチック製使い捨てLED膣鏡のグローバル市場 2021年：企業別、地域別、種類・用途別 The Plastic Disposable LED Vaginal Speculum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 人工・心肺用治療装置のグローバル市場 2021年：企業別、地域別、種類・用途別 The Heart and Lung Therapy System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 陰圧閉鎖療法ドレッシングキットのグローバル市場 2021年：企業別、地域別、種類・用途別 The Negative Pressure Wound Therapy Dressing Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 細胞治療用細胞凍結培地のグローバル市場 2021年：企業別、地域別、種類・用途別 The Cell Freezing Media for Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 膣用ペッサリーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Vaginal Pessary market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…